Fusion Pharmaceuticals Inc.

FUSN · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$61,925$43,861$52,898$90,517
Short-Term Investments$172,153$127,013$147,897$131,882
Receivables$4,215$1,723$357$794
Inventory$0-$9,869$0$4,244
Other Curr. Assets$5,102$509$233$727
Total Curr. Assets$243,395$178,998$211,762$228,164
Property Plant & Equip (Net)$23,896$10,315$9,453$1,967
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$14,584$15,761$19,987$77,082
Tax Assets$3,961$4,806$1,645$653
Other NC Assets$849$9,184$9,424$2,810
Total NC Assets$42,441$40,066$40,509$82,512
Other Assets$0$0$0$0
Total Assets$285,836$219,064$252,271$310,676
Liabilities
Payables$1,860$2,686$2,195$3,399
Short-Term Debt$4,163$1,443$1,215$0
Tax Payable$301$299$297$2,799
Deferred Revenue$333$924$1,538$1,000
Other Curr. Liab.$9,563$9,715$7,266$4,659
Total Curr. Liab.$16,220$15,067$12,511$11,857
LT Debt$34,775$38,810$5,507$0
Deferred Rev, NC$667$2,667$2,500$4,000
Deferred Tax Liab, NC$11,393$0$0$0
Other NC Liab.$301$299$297$306
Total NC Liab.$47,136$41,776$8,304$4,306
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$63,356$56,843$20,815$16,163
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$376,759-$281,862-$194,250-$113,203
AOCI$237-$469-$115$44
Other Equity$599,002$444,552$425,821$407,672
Total Equity$222,480$162,221$231,456$294,513
Supplemental Information
Minority Interest$0$0$0$310,676
Total Liab. & Tot. Equity$285,836$219,064$252,271$310,676
Net Debt-$22,987-$3,608-$46,176-$90,517